Table 1:

Demographics and preoperative risk-factors

	Overall—44, N (%)	Simultaneous—25, N (%)	Staged—19, N (%)	P-value
Male	30 (68)	13 (52)	17 (89)	0.01
Body mass index >31	8 (18)	5 (20)	3 (18)	0.27
Hypertension	41 (93)	24 (96)	17 (89)	0.57
Dyslipidaemia	40 (91)	22 (88)	18 (95)	0.62
Active smoker	9 (20)	5 (20)	4 (21)	0.53
History of smoke	22 (50)	11 (44)	11 (57)	0.28
Diabetes	9 (21)	5 (20)	4 (21)	1
Chronic obstructive pulmonary disease	15 (34)	8 (32)	7 (36)	0.75
Coronary artery disease	27 (61)	13 (52)	14 (74)	0.21
Atrial fibrillation	10 (23)	6 (24)	4 (21)	0.47
Cerebral vascular insufficiency	7 (16)	3 (12)	4 (21)	0.21
Peripheral arterial occlusive disease	8 (18)	5 (20)	3 (16)	1.0
Chronic renal failure	20 (45)	12 (48)	8 (42)	0.13
Dialysis	0 (0)	0 (0)	0 (0)	–
History of heart failure (within 3 months)	14 (32)	9 (36)	5 (26)	0.60
Active heart failure	5 (11)	3 (12)	2 (12)	1
Medical therapy
Dual antiplatelet	13 (30)	6 (24)	7 (36)	0.57
Anticoagulant therapy	13 (30)	8 (32)	5 (26)	0.74
Statin	42 (96)	23 (92)	19 (100)	0.49
Previous infrarenal aortic repair	7 (16)	3 (12)	4 (21)	0.44
Surgical	3 (7)	1 (4)	2 (12)	0.60
Endovascular	5 (11)	2 (8)	3 (18)	0.63
American Score of Anesthesiologist
3	14 (32)	6 (24)	8 (42)	0.32
4	30 (68)	19 (76)	11 (57)	0.33
Hostile bilateral femoral/iliac access	11 (25)	6 (24)	5 (26)	0.89
	Median (IQR)	Median (IQR)	Median (IQR)
Age (years)	82 (78–86)	81 (76–86)	83 (79–87)	0.32
Preoperative creatinine (mg/dl)	1.3 (0.9–1.7)	1.2 (1.0–1.4)	1.3 (1.1–1.5)	0.43
Preoperative eGFR (ml/min)	59 (45–73)	59 (44–73)	58 (45–71)	0.23
Aneurysm diameter (mm)	58 (55–61)	57 (55–59)	61 (57–65)	0.07

IQR: interquartile-range; N: numbers.